Following the recent positive results of its pivotal GLP pre-clinical study, the Company added a CRA to facilitate the company s first in human clinical studyBRAINTREE, Mass., Jan. 18, 2024 .
Microbot Medical Inc. (NASDAQ:MBOT – Get Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalling 27,900 shares, a decrease of 53.0% from the December 15th total of 59,300 shares. Based on an average daily volume of 882,600 shares, […]
Microbot Medical Inc. announced the successful completion of its GLP pivotal pre-clinical study, done under the guidelines of FDA-required levels of planning, controlling, monitoring, and reporting,.
Microbot Medical said Thursday that it has completed its good laboratory practice, or GLP, preclinical study of the Liberty endovascular robotic surgical system using a porcine model, and the.